Hanmi Pharmaceutical Company Limited: all 189 studies

Page 1 of 2. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With HypertensionRecruitingNCT07784296
• A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential HypertensionNot yet recruitingNCT07660796Phase 3
• Study to Evaluate HM15275 in Subjects With Type 2 Diabetes MellitusRecruitingNCT07527650Phase 2
• Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant MelanomaRecruitingNCT07449754Phase 2
• A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and DapagliflozinRecruitingNCT07379333Phase 3
• A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in Healthy VolunteersNot yet recruitingNCT07297693Phase 1
• A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese ParticipantsRecruitingNCT07219589Phase 1
• Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid TumorsRecruitingNCT06724016Phase 1
• Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid TumorsRecruitingNCT06234397Phase 1
• Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF SubjectsRecruitingNCT04775706Phase 2
• Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney FunctionCompletedNCT05711381Phase 1Results posted
• FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric CancerCompletedNCT04768686Phase 2Results posted
• Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With ComorbiditiesCompletedNCT04167553Phase 1Results posted
• Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912(Sonefpeglutide) in Healthy Korean SubjectsCompletedNCT04076293Phase 1Results posted
• A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLDCompletedNCT03744182Phase 1Results posted
• A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)CompletedNCT03374241Phase 1Results posted
• Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and ExerciseCompletedNCT03353350Phase 3Results posted
• Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405CompletedNCT02387554Phase 1Results posted
• Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid MalignanciesCompletedNCT01463982Phase 1Results posted
• Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes MellitusActive, not recruitingNCT07205900Phase 2
• A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain PatientsCompletedNCT06595004Phase 3
• A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy VolunteersCompletedNCT06518122Phase 1
• A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.CompletedNCT06481098Phase 1
• A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential HypertensionCompletedNCT06438172Phase 3
• A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed ConditionsCompletedNCT06357910Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy VolunteersCompletedNCT06346184Phase 1
• A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes MellitusCompletedNCT06174779Phase 3
• A Study to Evaluate Efficacy and Safety of HGP2304 in Essential Hypertension PatientsCompletedNCT06174766Phase 3
• A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy VolunteersCompletedNCT05862090Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male VolunteersCompletedNCT05737082Phase 1
• A Study to Evaluate the PK, Safety and Tolerability of HCP1803.CompletedNCT05723549Phase 1
• A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients with Gastric UlcerCompletedNCT05656092Phase 3
• Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid TumorsActive, not recruitingNCT05598151Phase 1
• An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With DyslipidemiaCompletedNCT05555238
• A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed ConditionsCompletedNCT05548543Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy VolunteersCompletedNCT05548387Phase 1
• An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal BleedingCompletedNCT05487560
• A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203CompletedNCT05481307Phase 1
• An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus TabletCompletedNCT05462535
• A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension PatientsCompletedNCT05450601Phase 3
• An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q TabletCompletedNCT05450575
• An Observational Study of Tamsulosin in Patients With Benign Prostatic HyperplasiaCompletedNCT05422677
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers.CompletedNCT05407220Phase 1
• A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential HypertensionCompletedNCT05362110Phase 3
• Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension PatientsCompletedNCT05199129Phase 3
• A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.CompletedNCT05191563Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy VolunteersCompletedNCT05155995Phase 1
• Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic GastritisCompletedNCT05024721Phase 3
• Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy VolunteersCompletedNCT04975711Phase 1
• Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy VolunteersCompletedNCT04967014Phase 1
• A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential HypertensionCompletedNCT04959305Phase 2
• A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008CompletedNCT04946903Phase 1
• Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension PatientsCompletedNCT04830449Phase 3
• Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in KoreaCompletedNCT04829149
• Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension PatientsCompletedNCT04820907Phase 3
• An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/CholecalciferolCompletedNCT04788290
• The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy VolunteersCompletedNCT04764201Phase 1
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903CompletedNCT04762407Phase 1
• HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)Active, not recruitingNCT04732416Phase 2
• Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.CompletedNCT04654702
• Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary HypercholesterolemiaCompletedNCT04652349Phase 3
• Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKITerminatedNCT04510415Phase 1
• Efocipegtrutide (HM15211) in Adults With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)CompletedNCT04505436Phase 2
• Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular DiseaseStatus unknownNCT04346862Phase 4
• Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux DiseaseCompletedNCT04325620Phase 3
• Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic RhinitisCompletedNCT04324918Phase 3
• Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy VolunteersCompletedNCT04324905Phase 1
• A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.CompletedNCT04322266Phase 1
• Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)Status unknownNCT04252963Phase 4
• Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male VolunteersCompletedNCT04252872Phase 1
• Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy SubjectsCompletedNCT04204629Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of HIP1701 in Healthy SubjectsCompletedNCT04087525Phase 1
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects.CompletedNCT04084197Phase 1
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy SubjectsCompletedNCT04084184Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy SubjectsCompletedNCT04081857Phase 1
• A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.CompletedNCT04081844Phase 1
• Efficacy and Safety of HIP1601 CapsuleCompletedNCT04080726Phase 3
• A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and DyslipidemiaCompletedNCT04074551Phase 3
• Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion MutationTerminatedNCT04044170Phase 2
• Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male VolunteersCompletedNCT04039724Phase 1
• A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy SubjectsCompletedNCT04032782Phase 1
• A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential HypertensionCompletedNCT03897868Phase 2
• Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male SubjectsCompletedNCT03882112Phase 1
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy SubjectsCompletedNCT03826641Phase 1
• Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV DiseaseCompletedNCT03666351Phase 4
• Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole FormulationsStatus unknownNCT03372850Phase 1
• PK and Safety Study of HCP1102, HGP0813 and HGP1408CompletedNCT03371849Phase 1
• Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes MellitusStatus unknownNCT03332849Phase 1
• Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes MellitusTerminatedNCT03332836Phase 1
• Molar Potency Study of HM12470 in Healthy SubjectsCompletedNCT03330327Phase 1
• Molar Potency Study of HM12460A in Healthy SubjectsCompletedNCT03330314Phase 1
• HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT03284502Phase 1
• Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid CancersCompletedNCT03118817Phase 1
• Clinical Trial on Education Method of Fluterol® Inhalation Inhaler for Asthma ControlCompletedNCT03110874Phase 4
• Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501CompletedNCT03089112Phase 1
• Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male VolunteersCompletedNCT02941848Phase 1
• Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male VolunteersCompletedNCT02941796Phase 1
• Evaluating the Bioequivalence of HIP1403 and HGP0919 SuspensionsCompletedNCT02941731Phase 1
• Clinical Efficacy and Safety Evaluation of HCP1202 in COPD PatientsStatus unknownNCT02941679Phase 3
• Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male VolunteersCompletedNCT02940314Phase 1

← Hanmi Pharmaceutical Company Limited overview and focus areas